Physician profile
Eric S Johnson
NPI 1558637272
$6,465.36
in general payments reported to CMS, 2019-2025
9 companies · $2,398 in 2025
The $2,398 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $145 · 2024: $3,923 · 2025: $2,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,020 · Travel and Lodging: $1,156 · Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,020.00 |
| Travel and Lodging | $1,156.05 |
| Food and Beverage | $1,144.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,202.02 | 2024-2025 | |
| Davol INC. | $359.82 | 2025 | Phasix Mesh |
| Boston Scientific Corporation | $253.56 | 2025 | Spyglass Discover, General - Vascular Intervention |
| Inari Medical, INC. | $181.28 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acera Surgical, INC. | $159.26 | 2025 | Restrata Wound Matrix |
| Tela Bio, INC. | $145.16 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Haemonetics Corporation | $19.26 | 2024 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.